Project

SAKK 08/15 PROMET

Ongoing - recruitment closed · 2017 until 2030

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2017
End Date
2030
Financing
SAKK
Study Design
International multicenter, randomized phase II trial.
Brief description/objective

PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy

The main objective of the trial is to explore the efficacy of SRT plus metformin compared to SRT in the endpoint of time to progression after prostatectomy failure.